PBYIHealthcareMicro-Cap
PUMA BIOTECHNOLOGY, INC. Insider Trading Activity
Every SEC Form 4 insider transaction reported for PUMA BIOTECHNOLOGY, INC. (PBYI), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are PBYI insiders buying or selling?
PUMA BIOTECHNOLOGY, INC. insiders reported 0 open-market buys ($0) and 225 sells ($9.2M) across 225 Form 4 filings — a net selling position of $9.2M.
Source: SEC EDGAR Form 4
Key Statistics (as of Jul 9, 2026)
Total Form 4 filings
225
SEC EDGAR
Insider filers
16
Insider buys (0)
$0
Insider sells (225)
$9.2M
Insider sentiment
Net sellingNet insider flow of $9.2M in net selling.
Recent PBYI insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 9, 2026 | Alan H Auerbach | President and CEO | Sale | 44.1K | $8.26 | $364.1K |
| Jul 9, 2026 | Douglas M Hunt | The Reporting Person is the Senior Vice President of Regulatory Affairs of the Issuer. | Sale | 8.5K | $8.26 | $69.9K |
| Jul 9, 2026 | Maximo F Nougues | Chief Financial Officer | Sale | 9.4K | $8.26 | $77.6K |
| Jun 16, 2026 | Troy Edward Wilson | Director | Sale | 10.8K | $7.20 | $77.7K |
| Jun 16, 2026 | Brian M Stuglik | Director | Sale | 8.1K | $7.20 | $58.3K |
| Jun 16, 2026 | Adrian Senderowicz | Director | Sale | 27.0K | $7.20 | $194.3K |
| Jun 16, 2026 | Jay M Moyes | Director | Sale | 22.0K | $7.22 | $158.8K |
| Jun 16, 2026 | Allison Dorval | Director | Sale | 11.6K | $7.20 | $83.6K |
| Jan 9, 2026 | Alan H Auerbach | President and CEO | Sale | 35.0K | $5.86 | $204.9K |
| Jan 9, 2026 | Douglas M Hunt | The Reporting Person is the Senior Vice President of Regulatory Affairs of the Issuer. | Sale | 9.0K | $5.86 | $52.7K |
| Jan 9, 2026 | Maximo F Nougues | Chief Financial Officer | Sale | 10.9K | $5.86 | $64.2K |
| Nov 13, 2025 | Michael Patrick Miller | Director | Sale | 20.0K | $4.86 | $97.2K |
| Jul 22, 2025 | Alessandra Cesano | Director | Sale | 27.0K | $3.37 | $90.9K |
| Jul 11, 2025 | Maximo F Nougues | Chief Financial Officer | Sale | 9.5K | $3.53 | $33.6K |
| Jul 11, 2025 | Douglas M Hunt | The Reporting Person is the Senior Vice President of Regulatory Affairs of the Issuer. | Sale | 7.8K | $3.53 | $27.6K |
| Jul 11, 2025 | Alan H Auerbach | President and CEO | Sale | 47.2K | $3.53 | $166.7K |
| Jun 17, 2025 | Troy Edward Wilson | Director | Sale | 10.8K | $3.40 | $36.7K |
| Jun 17, 2025 | Brian M Stuglik | Director | Sale | 8.1K | $3.39 | $27.5K |
| Jun 17, 2025 | Adrian Senderowicz | Director | Sale | 27.0K | $3.40 | $91.8K |
| Jun 17, 2025 | Jay M Moyes | Director | Sale | 22.0K | $3.40 | $74.8K |
| Jun 17, 2025 | Allison Dorval | Director | Sale | 11.6K | $3.40 | $39.5K |
| Jun 17, 2025 | Alessandra Cesano | Director | Sale | 12.2K | $3.40 | $41.3K |
| Jan 4, 2025 | Maximo F Nougues | Chief Financial Officer | Sale | 10.2K | $3.15 | $32.2K |
| Jan 4, 2025 | Jeffrey Jerome Ludwig | Chief Commercial Officer | Sale | 9.4K | $3.15 | $29.7K |
| Jan 4, 2025 | Douglas M Hunt | The Reporting Person is the Senior Vice President of Regulatory Affairs of the Issuer. | Sale | 8.6K | $3.15 | $27.2K |
Showing the 25 most recent of 225 Form 4 filings for PUMA BIOTECHNOLOGY, INC..
Most active PBYI insiders
- Alan H Auerbach59 filings
- Douglas M Hunt37 filings
- Maximo F Nougues33 filings
- Richard Paul Bryce31 filings
- Alvin F Wong9 filings
Ask anything about PBYI insider activity
Use Trabud's AI agent to query PUMA BIOTECHNOLOGY, INC.'s Form 4 history in plain English — "Show me PBYI CEO purchases this year" or compare it against any other ticker.
Open the AI agentPBYI insider trading FAQ
Are PUMA BIOTECHNOLOGY, INC. insiders buying or selling?
Across 225 SEC Form 4 filings, PUMA BIOTECHNOLOGY, INC. (PBYI) insiders reported 0 open-market purchases totaling $0 and 225 sales totaling $9.2M. That is a net selling position of $9.2M.
How many insiders trade PBYI stock?
16 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for PUMA BIOTECHNOLOGY, INC.. The most recent filing was accepted on Jul 9, 2026.
Where does Trabud get PBYI insider trading data?
All PBYI insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.